Skip to main content
Top
Published in: BMC Health Services Research 1/2014

Open Access 01-12-2014 | Research article

Practice characteristics and prior authorization costs: secondary analysis of data collected by SALT-Net in 9 central New York primary care practices

Authors: John W Epling, Emily M Mader, Christopher P Morley

Published in: BMC Health Services Research | Issue 1/2014

Login to get access

Abstract

Background

An increase in prior authorization (PA) requirements from health insurance companies is placing administrative and financial burdens on primary care offices across the United States. As time allocation for these cases continues to grow, physicians are concerned with additional workload and inefficiency in the workplace. The objective is to estimate the effects of practice characteristics on time spent per prior authorization request in primary care practices.

Methods

Secondary analysis was performed using data on nine primary care practices in Central New York. Practice characteristics and demographics were collected at the onset of the study. In addition, participants were instructed to complete an "event form" (EF) to document each prior authorization event during a 4–6 week period; prior authorizations included requests for medication as well as other health care services. Stepwise Ordinary Least Squares (OLS) Regression was used to model Time in Minutes of each event as an outcome of various factors.

Results

Prior authorization events (N = 435) took roughly 20 minutes to complete (beta = 20.017, p < .001); Medicaid requests took less time (beta = −6.085, p < .001), and Electronic Health Record (EHR) system use reduced prior authorization time by about 5 minutes (beta = −5.086, p = .002).

Conclusions

While prior authorization events impose substantial costs to primary care offices, it appears that Medicaid requests take less time than private payer requests. Results from the study provide support that Electronic Health Record usage may also reduce time required to complete prior authorization requests.
Literature
1.
go back to reference Hansen LB, Fernald D, Araya-Guerra R, Westfall JM, West D, Pace W: Pharmacy clarification of prescriptions ordered in primary care: a report from the Applied Strategies for Improving Patient Safety (ASIPS) collaborative. J Am Board Fam Med. 2006, 19 (1): 24-30. 10.3122/jabfm.19.1.24.CrossRefPubMed Hansen LB, Fernald D, Araya-Guerra R, Westfall JM, West D, Pace W: Pharmacy clarification of prescriptions ordered in primary care: a report from the Applied Strategies for Improving Patient Safety (ASIPS) collaborative. J Am Board Fam Med. 2006, 19 (1): 24-30. 10.3122/jabfm.19.1.24.CrossRefPubMed
2.
go back to reference Margolis JM, Cao Z, Onukwugha E, Sanchez RJ, Alvir J, Joshi AV, Mullins CD: Healthcare utilization and cost effects of prior authorization for pregabalin in commercial health plans. Am J Manag Care. 2010, 16 (6): 447-456.PubMed Margolis JM, Cao Z, Onukwugha E, Sanchez RJ, Alvir J, Joshi AV, Mullins CD: Healthcare utilization and cost effects of prior authorization for pregabalin in commercial health plans. Am J Manag Care. 2010, 16 (6): 447-456.PubMed
4.
5.
go back to reference Siracuse MV, Vuchetich PJ: Impact of Medicaid prior authorization requirement for COX-2 inhibitor drugs in Nebraska. Health Serv Res. 2008, 43 (1 Pt 2): 435-450.CrossRefPubMedPubMedCentral Siracuse MV, Vuchetich PJ: Impact of Medicaid prior authorization requirement for COX-2 inhibitor drugs in Nebraska. Health Serv Res. 2008, 43 (1 Pt 2): 435-450.CrossRefPubMedPubMedCentral
6.
go back to reference Gilchrist V, McCord G, Schrop SL, King BD, McCormick KF, Oprandi AM, Selius BA, Cowher M, Maheshwary R, Patel F, Shah A, Tsai B, Zaharna M: Physician activities during time out of the examination room. Ann Fam Med. 2005, 3 (6): 494-499. 10.1370/afm.391.CrossRefPubMedPubMedCentral Gilchrist V, McCord G, Schrop SL, King BD, McCormick KF, Oprandi AM, Selius BA, Cowher M, Maheshwary R, Patel F, Shah A, Tsai B, Zaharna M: Physician activities during time out of the examination room. Ann Fam Med. 2005, 3 (6): 494-499. 10.1370/afm.391.CrossRefPubMedPubMedCentral
7.
go back to reference Gottschalk A, Flocke SA: Time spent in face-to-face patient care and work outside the examination room. Ann Fam Med. 2005, 3 (6): 488-493. 10.1370/afm.404.CrossRefPubMedPubMedCentral Gottschalk A, Flocke SA: Time spent in face-to-face patient care and work outside the examination room. Ann Fam Med. 2005, 3 (6): 488-493. 10.1370/afm.404.CrossRefPubMedPubMedCentral
8.
go back to reference Tarn DM, Paterniti DA, Kravitz RL, Heritage J, Liu H, Kim S, Wenger NS: How much time does it take to prescribe a new medication?. Patient Educ Couns. 2008, 72 (2): 311-319. 10.1016/j.pec.2008.02.019.CrossRefPubMedPubMedCentral Tarn DM, Paterniti DA, Kravitz RL, Heritage J, Liu H, Kim S, Wenger NS: How much time does it take to prescribe a new medication?. Patient Educ Couns. 2008, 72 (2): 311-319. 10.1016/j.pec.2008.02.019.CrossRefPubMedPubMedCentral
9.
go back to reference Woolhandler S, Campbell T, Himmelstein DU: Costs of health care administration in the United States and Canada. N Engl J Med. 2003, 349 (8): 768-775. 10.1056/NEJMsa022033.CrossRefPubMed Woolhandler S, Campbell T, Himmelstein DU: Costs of health care administration in the United States and Canada. N Engl J Med. 2003, 349 (8): 768-775. 10.1056/NEJMsa022033.CrossRefPubMed
10.
go back to reference Bukstein DA, Cherayil GA, Gepner AD, Luskin AT, Kooistra JB, Olson RM: The economic burden associated with prior authorizations in an allergist office. Allergy Asthma Proc. 2006, 27 (2): 119-122.PubMed Bukstein DA, Cherayil GA, Gepner AD, Luskin AT, Kooistra JB, Olson RM: The economic burden associated with prior authorizations in an allergist office. Allergy Asthma Proc. 2006, 27 (2): 119-122.PubMed
11.
go back to reference Casalino LP, Nicholson S, Gans DN, Hammons T, Morra D, Karrison T, Levinson W: What does it cost physician practices to interact with health insurance plans?. Health Aff (Millwood). 2009, 28 (4): w533-43. 10.1377/hlthaff.28.4.w533.CrossRef Casalino LP, Nicholson S, Gans DN, Hammons T, Morra D, Karrison T, Levinson W: What does it cost physician practices to interact with health insurance plans?. Health Aff (Millwood). 2009, 28 (4): w533-43. 10.1377/hlthaff.28.4.w533.CrossRef
12.
go back to reference Sakowski JA, Kahn JG, Kronick RG, Newman JM, Luft HS: Peering into the black box: billing and insurance activities in a medical group. Health Aff (Millwood). 2009, 28 (4): w544-54. 10.1377/hlthaff.28.4.w544.CrossRef Sakowski JA, Kahn JG, Kronick RG, Newman JM, Luft HS: Peering into the black box: billing and insurance activities in a medical group. Health Aff (Millwood). 2009, 28 (4): w544-54. 10.1377/hlthaff.28.4.w544.CrossRef
13.
go back to reference Morra D, Nicholson S, Levinson W, Gans DN, Casalino LP, Hammons T: US physician practices versus Canadians: spending nearly four times as much money interacting with payers. Health Aff (Millwood). 2011, 30 (8): 1443-1450. 10.1377/hlthaff.2010.0893.CrossRef Morra D, Nicholson S, Levinson W, Gans DN, Casalino LP, Hammons T: US physician practices versus Canadians: spending nearly four times as much money interacting with payers. Health Aff (Millwood). 2011, 30 (8): 1443-1450. 10.1377/hlthaff.2010.0893.CrossRef
15.
go back to reference Morley CP, Badolato DJ, Hickner J, Epling JW: The impact of prior authorization requirements on primary care physicians' offices: report of two parallel network studies. J Am Board Fam Med. 2013, 26 (1): 93-95. 10.3122/jabfm.2013.01.120062.CrossRefPubMed Morley CP, Badolato DJ, Hickner J, Epling JW: The impact of prior authorization requirements on primary care physicians' offices: report of two parallel network studies. J Am Board Fam Med. 2013, 26 (1): 93-95. 10.3122/jabfm.2013.01.120062.CrossRefPubMed
17.
go back to reference Fontaine P, Ross SE, Zink T, Schilling LM: Systematic review of health information exchange in primary care practices. J Am Board Fam Med. 2010, 23 (5): 655-670. 10.3122/jabfm.2010.05.090192.CrossRefPubMed Fontaine P, Ross SE, Zink T, Schilling LM: Systematic review of health information exchange in primary care practices. J Am Board Fam Med. 2010, 23 (5): 655-670. 10.3122/jabfm.2010.05.090192.CrossRefPubMed
18.
go back to reference Irani JS, Middleton JL, Marfatia R, Omana ET, D'Amico F: The use of electronic health records in the exam room and patient satisfaction: a systematic review. J Am Board Fam Med. 2009, 22 (5): 553-562. 10.3122/jabfm.2009.05.080259.CrossRefPubMed Irani JS, Middleton JL, Marfatia R, Omana ET, D'Amico F: The use of electronic health records in the exam room and patient satisfaction: a systematic review. J Am Board Fam Med. 2009, 22 (5): 553-562. 10.3122/jabfm.2009.05.080259.CrossRefPubMed
19.
go back to reference Laing BY, Bodenheimer T, Phillips RL, Bazemore A, Bazemore A: Primary care's eroding earnings: is congress concerned?. J Fam Pract. 2008, 57 (9): 578-583.PubMed Laing BY, Bodenheimer T, Phillips RL, Bazemore A, Bazemore A: Primary care's eroding earnings: is congress concerned?. J Fam Pract. 2008, 57 (9): 578-583.PubMed
20.
go back to reference Kahan NR, Chinitz DP, Blackman S, Waitman D, Vardy DA: Modifying prescribing behaviour of angiotensin receptor blockers by selectively rescinding managerial prior authorization requirements for losartan. Br J Clin Pharmacol. 2011, 72 (6): 997-1001. 10.1111/j.1365-2125.2011.04044.x.CrossRefPubMedPubMedCentral Kahan NR, Chinitz DP, Blackman S, Waitman D, Vardy DA: Modifying prescribing behaviour of angiotensin receptor blockers by selectively rescinding managerial prior authorization requirements for losartan. Br J Clin Pharmacol. 2011, 72 (6): 997-1001. 10.1111/j.1365-2125.2011.04044.x.CrossRefPubMedPubMedCentral
21.
go back to reference Kahan NR, Chinitz DP, Waitman D, Kahan E: When gatekeepers meet the sentinel: the impact of a prior authorization requirement for cefuroxime on the prescribing behaviour of community-based physicians. Br J Clin Pharmacol. 2006, 61 (3): 341-4. 10.1111/j.1365-2125.2006.02577.x.CrossRefPubMedPubMedCentral Kahan NR, Chinitz DP, Waitman D, Kahan E: When gatekeepers meet the sentinel: the impact of a prior authorization requirement for cefuroxime on the prescribing behaviour of community-based physicians. Br J Clin Pharmacol. 2006, 61 (3): 341-4. 10.1111/j.1365-2125.2006.02577.x.CrossRefPubMedPubMedCentral
22.
go back to reference Fischer MA, Polinski JM, Servi AD, Agnew-Blais J, Kaci L, Solomon DH: Prior authorization for biologic disease-modifying antirheumatic drugs: a description of US Medicaid programs. Arthritis Rheum. 2008, 59 (11): 1611-7. 10.1002/art.24191.CrossRefPubMedPubMedCentral Fischer MA, Polinski JM, Servi AD, Agnew-Blais J, Kaci L, Solomon DH: Prior authorization for biologic disease-modifying antirheumatic drugs: a description of US Medicaid programs. Arthritis Rheum. 2008, 59 (11): 1611-7. 10.1002/art.24191.CrossRefPubMedPubMedCentral
23.
go back to reference Fischer MA, Choudhry NK, Winkelmayer WC: Impact of Medicaid prior authorization on angiotensin-receptor blockers: can policy promote rational prescribing?. Health Aff (Millwood ). 2007, 26 (3): 800-7. 10.1377/hlthaff.26.3.800.CrossRef Fischer MA, Choudhry NK, Winkelmayer WC: Impact of Medicaid prior authorization on angiotensin-receptor blockers: can policy promote rational prescribing?. Health Aff (Millwood ). 2007, 26 (3): 800-7. 10.1377/hlthaff.26.3.800.CrossRef
24.
go back to reference Lu CY, Law MR, Soumerai SB, Graves AJ, LeCates RF, Zhang F, Ross-Degnan D, Adams AS: Impact of prior authorization on the use and costs of lipid-lowering medications among Michigan and Indiana dual enrollees in Medicaid and Medicare: results of a longitudinal, population-based study. Clin Ther. 2011, 33 (1): 135-144. 10.1016/j.clinthera.2011.01.012.CrossRefPubMedPubMedCentral Lu CY, Law MR, Soumerai SB, Graves AJ, LeCates RF, Zhang F, Ross-Degnan D, Adams AS: Impact of prior authorization on the use and costs of lipid-lowering medications among Michigan and Indiana dual enrollees in Medicaid and Medicare: results of a longitudinal, population-based study. Clin Ther. 2011, 33 (1): 135-144. 10.1016/j.clinthera.2011.01.012.CrossRefPubMedPubMedCentral
25.
go back to reference Abouzaid S, Jutkowitz E, Foley KA, Pizzi LT, Kim E, Bates J: Economic impact of prior authorization policies for atypical antipsychotics in the treatment of schizophrenia. Popul Health Manag. 2010, 13 (5): 247-254. 10.1089/pop.2009.0063.CrossRefPubMed Abouzaid S, Jutkowitz E, Foley KA, Pizzi LT, Kim E, Bates J: Economic impact of prior authorization policies for atypical antipsychotics in the treatment of schizophrenia. Popul Health Manag. 2010, 13 (5): 247-254. 10.1089/pop.2009.0063.CrossRefPubMed
26.
go back to reference Law MR, Lu CY, Soumerai SB, Graves AJ, LeCates RF, Zhang F, Ross-Degnan D, Adams AS: Impact of two Medicaid prior-authorization policies on antihypertensive use and costs among Michigan and Indiana residents dually enrolled in Medicaid and Medicare: results of a longitudinal, population-based study. Clin Ther. 2010, 32 (4): 729-41. 10.1016/j.clinthera.2010.04.007. discussion 716CrossRefPubMed Law MR, Lu CY, Soumerai SB, Graves AJ, LeCates RF, Zhang F, Ross-Degnan D, Adams AS: Impact of two Medicaid prior-authorization policies on antihypertensive use and costs among Michigan and Indiana residents dually enrolled in Medicaid and Medicare: results of a longitudinal, population-based study. Clin Ther. 2010, 32 (4): 729-41. 10.1016/j.clinthera.2010.04.007. discussion 716CrossRefPubMed
27.
go back to reference Bazalo G, Weiss RC, Joshi AV: Impact of a prior authorization for pregabalin on health plan drug expenditures. Am J Manag Care. 2010, 16 (5 Suppl): S154-9.PubMed Bazalo G, Weiss RC, Joshi AV: Impact of a prior authorization for pregabalin on health plan drug expenditures. Am J Manag Care. 2010, 16 (5 Suppl): S154-9.PubMed
28.
go back to reference Martin JC, Avant RF, Bowman MA, Bucholtz JR, Dickinson JR, Evans KL, Green LA, Henley DE, Jones WA, Matheny SC, Nevin JE, Panther SL, Puffer JC, Roberts RG, Rodgers DV, Sherwood RA, Stange KC, Weber CW: Future of family medicine project leadership committee: the future of family medicine: a collaborative project of the family medicine community. Ann Fam Med. 2004, 2 (Suppl 1): S3-32.PubMed Martin JC, Avant RF, Bowman MA, Bucholtz JR, Dickinson JR, Evans KL, Green LA, Henley DE, Jones WA, Matheny SC, Nevin JE, Panther SL, Puffer JC, Roberts RG, Rodgers DV, Sherwood RA, Stange KC, Weber CW: Future of family medicine project leadership committee: the future of family medicine: a collaborative project of the family medicine community. Ann Fam Med. 2004, 2 (Suppl 1): S3-32.PubMed
29.
go back to reference Rosenthal TC: The medical home: growing evidence to support a new approach to primary care. J Am Board Fam Med. 2008, 21 (5): 427-440. 10.3122/jabfm.2008.05.070287.CrossRefPubMed Rosenthal TC: The medical home: growing evidence to support a new approach to primary care. J Am Board Fam Med. 2008, 21 (5): 427-440. 10.3122/jabfm.2008.05.070287.CrossRefPubMed
30.
go back to reference Nicoletti B: Primary care: life in the pressure cooker. J Med Pract Manage. 2008, 23 (6): 343-344.PubMed Nicoletti B: Primary care: life in the pressure cooker. J Med Pract Manage. 2008, 23 (6): 343-344.PubMed
Metadata
Title
Practice characteristics and prior authorization costs: secondary analysis of data collected by SALT-Net in 9 central New York primary care practices
Authors
John W Epling
Emily M Mader
Christopher P Morley
Publication date
01-12-2014
Publisher
BioMed Central
Published in
BMC Health Services Research / Issue 1/2014
Electronic ISSN: 1472-6963
DOI
https://doi.org/10.1186/1472-6963-14-109

Other articles of this Issue 1/2014

BMC Health Services Research 1/2014 Go to the issue